Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses

por Kouokam, Joseph Calvin, Lasnik, Amanda B., Palmer, Kenneth E.
Publicado 2016

Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin

por Nabeta, Henry W., Kouokam, Joseph C., Lasnik, Amanda B., Fuqua, Joshua L., Palmer, Kenneth E.
Publicado 2021

Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis

por Nabeta, Henry W., Lasnik, Amanda B., Fuqua, Joshua L., Wang, Lin, Rohan, Lisa C., Palmer, Kenneth E.
Publicado 2022

Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention

por Kramzer, Lindsay F., Hamorsky, Krystal T., Graebing, Phillip W., Wang, Lin, Fuqua, Joshua L., Matoba, Nobuyuki, Lasnik, Amanda B., Moncla, Bernard J., Zhang, Junmei, Palmer, Kenneth E., Rohan, Lisa C.
Publicado 2021

Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients

por Rouchka, Eric C., Chariker, Julia H., Alejandro, Brian, Adcock, Robert S., Singhal, Richa, Ramirez, Julio, Palmer, Kenneth E., Lasnik, Amanda B., Carrico, Ruth, Arnold, Forest W., Furmanek, Stephen, Zhang, Mei, Wolf, Leslie A., Waigel, Sabine, Zacharias, Wolfgang, Bordon, Jose, Chung, Donghoon
Publicado 2021